在HFrEF患者中,萨库比特里尔/瓦尔萨坦可以提高睡眠质量并减少白天功能障碍吗?
Seçkin Dereli1, Onur Osman Şeker2
1Faculty of Medicine, Deparment of Cardiology, Ordu University, Ordu, Turkey. drseckindereli@gmail.com.
Sleep & breathing = Schlaf & Atmung
|December 10, 2025
概括
萨库比特里尔/瓦尔萨坦 (SV) 显著改善了心力衰竭患者的睡眠质量和白天警觉,心力衰竭患者心力衰竭患者心力衰竭患者心力衰竭患者心力衰竭患者心力衰竭患者心力衰竭患者. 这种治疗也提高了运动能力,为HFrEF管理提供了双重好处.
科学领域:
- 心脏病学 心脏病学
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 充血性心力衰竭 (CHF) 影响全球数以百万计的人,特别是老年人,并且经常与睡眠障碍并存,恶化结果.
- 优化心力衰竭管理至关重要,特别是在心力衰竭与减少喷射率 (HFrEF) 的心力衰竭中,正在进行呼吸治疗的研究.
- 萨库比特里尔/瓦尔萨坦 (SV) 显示出降低心血管死亡率和住院病人的潜力,但其对HFrEF患者睡眠的影响尚不清楚.
研究的目的:
- 预期评估sacubitril/valsartan (SV) 对心力衰竭患者的睡眠质量和白天警觉性的影响.
- 为了评估左心室喷射率 (LVEF) 和运动能力在HFrEF患者SV治疗后的变化.
- 在HFrEF中探索SV在改善心血管和睡眠相关结果方面的潜在双重治疗益处.
主要方法:
- 一项前性,队列性,开放标签研究,涉及HFrEF患者 (LVEF<40%,NYHA类II-IV) 优化医疗管理.
- 患者从ACE抑制剂或ARB转换为SV,剂量调整和定期临床评估.
- 睡眠质量 (匹兹堡睡眠质量指数 - PSQI) 和白天警觉 (爱普沃思睡眠度量表 - ESS) 在基线和达到目标SV剂量后被测量. 使用6分钟步行测试 (6-MWT) 评估功能能力.
主要成果:
- 在平均随访132天后,SV治疗导致PSQI得分 (p < 0.001) 和ESS得分 (p < 0.001) 显著改善.
- 患者在LVEF (p < 0.001) 和6-MWT距离 (p = 0.002) 中显著增加.
- 睡眠质量差 (PSQI > 5) 和过度白天嗜睡 (ESS ≥ 11) 的几率显著降低 (p < 0.001).
结论:
- 萨库比特里尔/瓦尔萨坦 (SV) 在改善HFrEF患者的睡眠质量和减少白天功能障碍方面表现出有效性.
- 该研究强调了SV的潜在双重治疗益处,增强了心血管功能和睡眠参数.
- 需要进一步的研究,以充分阐明SV对这种患者群体睡眠和生活质量的影响.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
228
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
228
01:30Heart Failure V: Medical Management
195
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
195
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
869
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
869
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
325
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
325
01:24Substance Use Disorders Affecting Sleep
357
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
357
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
470
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
470